Literature DB >> 10890611

Effect of inhaled nitric oxide on key mediators of the inflammatory response in patients with acute lung injury.

B H Cuthbertson1, H F Galley, N R Webster.   

Abstract

OBJECTIVE: Inhaled nitric oxide is used to treat hypoxia associated with acute lung injury. Endogenous nitric oxide regulates inflammatory responses, but the effect of inhaled nitric oxide therapy is unknown. We hypothesized that inhaled nitric oxide may alter inflammatory responses and endogenous nitric oxide synthase activity.
DESIGN: A randomized, prospective interventional study.
SETTING: A university hospital's general intensive care unit. PATIENTS: Thirty-two patients with acute lung injury.
INTERVENTIONS: Patients who responded to test doses of nitric oxide were randomized to ventilator therapy with and without inhaled nitric oxide. The inhaled concentration of nitric oxide was determined by dose titration at 0, 2, 10, and 40 ppm and the minimum concentration used, which resulted in an increase in the PaO2/FIO2 ratio of at least 25%.
MEASUREMENTS AND MAIN RESULTS: Patients were followed up for 30 days or until death, and bronchoalveolar lavage (BAL) was performed at 0, 24, and 72 hrs. Nitric oxide synthase activity was measured spectrophotometrically, and myeloperoxidase, elastase, interleukin-8, and leukotrienes were measured in BAL fluid by enzyme immunoassay. Total nitrite and lipid peroxides in serum were measured colorimetrically. Nitric oxide synthase activity decreased (p = .01) and total nitrite increased (p = .02) in patients receiving inhaled nitric oxide. Other markers of inflammation in BAL fluid did not change. Lipid peroxide concentrations also did not alter.
CONCLUSIONS: The decrease in activity of nitric oxide synthase in patients receiving nitric oxide is likely to be the result of feedback inhibition of the enzyme. This study shows that inhaled nitric oxide has no effect on several markers of the inflammatory response system and does not lead to increased oxidant stress.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10890611     DOI: 10.1097/00003246-200006000-00006

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

1.  Inhaled nitric oxide increases endothelial permeability in Pseudomonas aeruginosa pneumonia.

Authors:  Florence Ader; Rozenn Le Berre; Steve Lancel; Karine Faure; Nathalie B Viget; Emmanuel Nowak; Rémi Nevière; Benoit P Guery
Journal:  Intensive Care Med       Date:  2007-01-12       Impact factor: 17.440

Review 2.  Balancing the risks and benefits of oxygen therapy in critically III adults.

Authors:  G R Scott Budinger; Gökhan M Mutlu
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

3.  Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation.

Authors:  Amarjit S Naura; Mourad Zerfaoui; Hogyoung Kim; Zakaria Y Abd Elmageed; Paulo C Rodriguez; Chetan P Hans; Jihang Ju; Youssef Errami; Jiwon Park; Augusto C Ochoa; A Hamid Boulares
Journal:  J Immunol       Date:  2010-07-28       Impact factor: 5.422

4.  ARDS Clinical Practice Guideline 2021.

Authors:  Sadatomo Tasaka; Shinichiro Ohshimo; Muneyuki Takeuchi; Hideto Yasuda; Kazuya Ichikado; Kenji Tsushima; Moritoki Egi; Satoru Hashimoto; Nobuaki Shime; Osamu Saito; Shotaro Matsumoto; Eishu Nango; Yohei Okada; Kenichiro Hayashi; Masaaki Sakuraya; Mikio Nakajima; Satoshi Okamori; Shinya Miura; Tatsuma Fukuda; Tadashi Ishihara; Tetsuro Kamo; Tomoaki Yatabe; Yasuhiro Norisue; Yoshitaka Aoki; Yusuke Iizuka; Yutaka Kondo; Chihiro Narita; Daisuke Kawakami; Hiromu Okano; Jun Takeshita; Keisuke Anan; Satoru Robert Okazaki; Shunsuke Taito; Takuya Hayashi; Takuya Mayumi; Takero Terayama; Yoshifumi Kubota; Yoshinobu Abe; Yudai Iwasaki; Yuki Kishihara; Jun Kataoka; Tetsuro Nishimura; Hiroshi Yonekura; Koichi Ando; Takuo Yoshida; Tomoyuki Masuyama; Masamitsu Sanui
Journal:  J Intensive Care       Date:  2022-07-08

Review 5.  Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults.

Authors:  Fabienne Gebistorf; Oliver Karam; Jørn Wetterslev; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2016-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.